A new international multicenter study published in the Journal of Cellular and Molecular Medicine provides important real-world evidence on the use of CD19-targeted chimeric antigen receptor (CAR) ...
Ochsner Health, in partnership with MD Anderson, has established multiple cancer centers throughout the state of Louisiana, ...
Presented at the American Heart Association (AHA) 2025 Scientific Sessions, the new guidelines emphasize tighter systolic BP ...
Panelists discuss how aligning evolving payer policies with real-world oncology practice is key to sustaining timely and ...
Papillary muscle scarring (papSCAR) as detected by dark blood delayed-enhancement cardiovascular magnetic resonance (CMR) was ...
Panelists discuss how removing LDL-C targets in 2013 shifted focus from outcomes to statin use, weakening control efforts.
Melanie Sheen, MD, describes efforts to boost diverse clinical trial enrollment through trust, community partnerships, and ...
Panelists discuss how national policy reforms are reshaping oncology care by balancing affordability efforts with the need to ...
Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...
The US pharmaceutical supply chain relies heavily on imports, with roughly 80% of APIs sourced from China and India. 2 Tariffs could raise input costs, trigger retaliatory trade measures, or ...
AI enhances breast cancer care by improving mammography accuracy, reducing false negatives, and aiding in clinical trial enrollment and design. AI-driven digital patient profiling reduces placebo use ...
Natera's integration into OncoEMR enhances workflow efficiency, simplifying the ordering process for precision medicine tests in oncology practices. The integration supports timely treatment decisions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback